Literature DB >> 18561177

Genetic diagnosis of alveolar rhabdomyosarcoma in the bone marrow of a patient without evidence of primary tumor.

Susana Lisboa1, Nuno Cerveira, Joana Vieira, Lurdes Torres, Ana Maia Ferreira, Mariana Afonso, Lucília Norton, Rui Henrique, Manuel R Teixeira.   

Abstract

Alveolar rhabdomyosarcoma (ARMS) is characterized by two pathognomonic translocations, both involving the FOXO1 gene. We describe a case of a 10-year-old child with multiple lytic lesions involving all the vertebral bodies, sternum and femur and a bone marrow biopsy compatible with a small round cell neoplasia, but no evidence of a primary tumor. Interphase FISH analysis with specific probes evidenced a rearrangement involving the FOXO1 gene and RT-PCR identified the PAX7-FOXO1 fusion transcript. These data show a case of ARMS with no evidence of primary tumor presenting the PAX7-FOXO1 fusion gene. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18561177     DOI: 10.1002/pbc.21646

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  5 in total

Review 1.  Developmental origins of fusion-negative rhabdomyosarcomas.

Authors:  Ken Kikuchi; Brian P Rubin; Charles Keller
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

2.  Muscling in: Uncovering the origins of rhabdomyosarcoma.

Authors:  Simone Hettmer; Amy J Wagers
Journal:  Nat Med       Date:  2010-02       Impact factor: 53.440

Review 3.  Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems.

Authors:  Venkatesh P Kashi; Mark E Hatley; Rene L Galindo
Journal:  Nat Rev Cancer       Date:  2015-07       Impact factor: 60.716

4.  Bioinformatics Analysis and Validation Identify CDK1 and MAD2L1 as Prognostic Markers of Rhabdomyosarcoma.

Authors:  Suying Lu; Chengtao Sun; Huimou Chen; Chao Zhang; Wei Li; Liuhong Wu; Jia Zhu; Feifei Sun; Junting Huang; Juan Wang; Zijun Zhen; Ruiqing Cai; Xiaofei Sun; Yizhuo Zhang; Xing Zhang
Journal:  Cancer Manag Res       Date:  2020-11-26       Impact factor: 3.989

5.  Lineage of origin in rhabdomyosarcoma informs pharmacological response.

Authors:  Jinu Abraham; Yaiza Nuñez-Álvarez; Simone Hettmer; Elvira Carrió; Hung-I Harry Chen; Koichi Nishijo; Elaine T Huang; Suresh I Prajapati; Robert L Walker; Sean Davis; Jennifer Rebeles; Hunter Wiebush; Amanda T McCleish; Sheila T Hampton; Christopher R R Bjornson; Andrew S Brack; Amy J Wagers; Thomas A Rando; Mario R Capecchi; Frank C Marini; Benjamin R Ehler; Lee Ann Zarzabal; Martin W Goros; Joel E Michalek; Paul S Meltzer; David M Langenau; Robin D LeGallo; Atiya Mansoor; Yidong Chen; Mònica Suelves; Brian P Rubin; Charles Keller
Journal:  Genes Dev       Date:  2014-07-15       Impact factor: 11.361

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.